Business
Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction
RICHMOND, Va., May 11, 2026--Accendra Health, Inc. (NYSE: ACH) today reported financial results for the first quarter ended March 31, 2026, and announced a more than $1.5 billion comprehensive balance sheet optimization transaction with commitments from existing creditors that will strengthen the balance sheet, significantly extend maturities and reduce total leverage. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which represent what was previously the
About this update from Accendra Health, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2029,"height":529,"url":"https://media.zenfs.com/en/business-wire.com/7b0e8bfe7d217f0dd96bf3d43bf8bbf8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/EwT3FvaxEwYBo_uqT_AttA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI1MA--/https://media.zenfs.com/en/business-wire.com/7b0e8bfe7d217f0dd96bf3d43bf8bbf8","width":960,"height":250},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/XmazZpkzeLjjFtDDrM6T3Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTE2Nw--/https://media.zenfs.com/en/business-wire.com/7b0e8bfe7d217f0dd96bf3d43bf8bbf8","width":640,"height":167},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/YaGh_tTHe3V8qNk6BMx25A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02MjY-/https://media.zenfs.com/en/business-wire.com/7b0e8bfe7d217f0dd96bf3d43bf8bbf8","width":1200,"height":313}},"lazy":false},{"type":"text","content":"Commitments in Place from Existing Creditors to Strengthen Balance Sheet, Extend Maturities, and Reduce Leverage","length":112,"tagName":"p","attribs":{}},{"type":"text","content":"RICHMOND, Va., May 11, 2026--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) today reported financial results for the first quarter ended March 31, 2026, and announced a more than $1.5 billion comprehensive balance sheet optimization transaction with commitments from existing creditors that will strengthen the balance sheet, significantly extend maturities and reduce total leverage. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which represent what was previously the Patient Direct segment and certain functional operations.","length":574,"tagName":"p"},{"type":"text","content":""Our first quarter results were aligned with our expectations as we continue our transformation into a pure play home based care company. We are also pleased to report that transition services and other separation activity related to our divestiture of Owens & Minor are on track and going according to schedule," said Edward A. Pesicka, President & Chief Executive Officer, Accendra Health.","length":409,"tagName":"p"},{"type":"text","content":""Also, this morning we announced the receipt of commitments from existing creditors that will allow us to conduct a holistic reset of our ca...